IL6R and COVID-19: Several antiviral drugs (PaxlovidTM [21], Remdesivir, Bebtelovimab [22], Molnupiravir [23], Andrographis [24,25,26]) and immune modulators (Olumiant, an interleukin-6 receptor blocker [27]) were approved by drug regulatory authorities for use against COVID-19 for treating non-hospitalized or hospitalized COVID-19 patients.